Latest Yasmin Stories

The US Drug Watchdog is expanding its national investigation of the birth control drugs called Yaz and Yasmin given increasing evidence these drugs may be responsible for serious pulmonary embolism's, deep vein thrombosis, heart attacks, strokes and other serious side affects with users. According to the New York Times, "In September of 2009, the Food and Drug Administration (FDA) cited Bayer for running misleading television commercials, and for not following proper...

The US Drug Watchdog is calling its Yaz, Yasmin, or the generic version of these birth control pills called Ocella, their most important women's health care initiative ever. The group says, "If a user of the birth control pills called Yaz, Yasmin, or the generic version Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other severe medical complications, while taking these birth control pills, we want to know about it. We are hearing horror stories...

Women Who Suffered Blood Clots After Using Yaz, Yasmin or Ocella Birth Control Pills May be Entitled to File Lawsuits to Recover Damages for Their Injuries Naples, FL (PRWEB) January 02, 2012 Recent research has indicated that young women who use Yaz, Yasmin, Ocella or other birth control pills containing the progestin, drospirenone, may face a higher risk of blood clots compared to those taking other oral contraceptives. Gilman Law LLP is actively investigating potential lawsuits on...

Ennis & Ennis, P.A. Explains FDA Advisory Committee Meeting Outcome Regarding Yaz and Yasmin (PRWEB) December 13, 2011 The US Food and Drug Administration (FDA) advisory committee voted 21-5 on Thursday that labeling on Bayer's popular Yaz and similar birth control pills is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs, compared with older oral contraceptives. Ennis & Ennis, P.A. explains the panelists want the label...

Parker Waichman Alonso LLP, a National Law Firm, Urges the FDA to Follow the Recommendation of its Outside Experts and Immediately Update the Labels of Yaz, Yasmin and Other Drospirenone Birth Control Pills with Stronger Warnings Regarding Their Association with a Higher Risk of Blood Clots New York, New York (PRWEB) December 09, 2011 Parker Waichman Alonso LLP urges the U.S. Food & Drug Administration (FDA) to accept the recommendation of its outside advisors to update the labels for...

Ennis & Ennis, P.A. Raises Questions about Yaz and Yasmin Ahead of the FDA Meeting (PRWEB) December 06, 2011 The Food and Drug Administration’s (FDA) primary responsibility is to ensure that all medications it evaluates and approves are safe for public use. The pharmaceutical companies presumably extensively research and test new medications and provide this data to the FDA’s Center for Drug Evaluation Research (CDER). Unfortunately, the CDER conducts no research or...

Craig Swapp & Associates is now helping clients who have suffered cardiovascular injuries after taking Yasmin®, YAZ® or Ocella®. Sandy, UT (PRWEB) December 02, 2011 Craig Swapp & Associates is now accepting personal injury cases where women’s health has been threatened by certain popular birth control drugs, including Yasmin and YAZ (or their generic equivalent Ocella). Says Attorney Craig Swapp, “The Food and Drug Administration has been investigating...

Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin. (PRWEB) November 09, 2011 The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney...

Women Who Take Certain Oral Contraceptive Pills such as Yaz or Yasmin Are More Likely to Develop Venous Thromboembolism, Explains Ennis & Ennis, P.A. (PRWEB) October 28, 2011 A study published on October 25, 2011 by The British Medical Journal confirms previous findings that certain oral contraceptives containing newer types of progestogen hormones (drospirenone, desogestrel or gestodene), which are found in Yaz or Yasmin, at least double the risk of developing venous thromboembolism...

The Consumer Justice Foundation, a team of consumer advocate professionals who provide online resources for consumers that relay information regarding dealing with insurance companies and the dangers of pharmaceutical medications and whose URL can be found at http://www.SideEffectsRX.com, hereby alerts the public of a joint meeting held by the FDA including the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee on December 8, 2011 to...